Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Importance of cost effective treatments for GU cancer

Daniel Geynisman • 13 Feb 2020
GU Cancers 2020
Genitourinary Cancer

Daniel Geynisman, MD, Fox Chase Cancer Center, Philadelphia, PA, gives his opinion on the importance of cost-effectiveness in the treatment of genitourinary (GU) cancers. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Daniel Geynisman

3:35
Real-world survival in mHSPC following abiraterone or docetaxel therapy
Daniel Geynisman • 14 Feb 2021
4:24
RETAIN BLADDER: a risk-adapted approach to muscle invasive bladder cancer
Daniel Geynisman • 14 Feb 2021
Kidney cancer: MK-6482 & sitravatinib with nivolumab
Daniel Geynisman • 16 Feb 2020

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals